期刊文献+

恶性肿瘤并发深静脉血栓形成43例临床分析 被引量:1

下载PDF
导出
摘要 目的:探讨恶性肿瘤合并深静脉血栓的临床特点、诊断方法及治疗原则。方法:回顾性分析43例恶性肿瘤合并深静脉血栓患者的诊断、治疗及生存情况。43例患者经过D-二聚体筛查、血管加压超声和/或磁共振血管成像检查确诊。全部患者接受了低分子肝素抗凝及改善循环治疗。结果:经治疗1月后,37(86%)例患者栓塞症状缓解。随访1年,31例死亡。1年生存率28%。结论:深静脉血栓是晚期恶性肿瘤的常见并发症,其发生发展与肿瘤进展及各种抗肿瘤措施有一定的相关性。具有潜在的致死性,治疗复杂,预后不良。抗凝治疗为此类患者的基础治疗,具有良好的安全性。
出处 《现代肿瘤医学》 CAS 2011年第10期2059-2061,共3页 Journal of Modern Oncology
  • 相关文献

参考文献10

  • 1Sutherland DE,Weitz IC,Liebman HA.Thromboembolic complications of cancer:epidemiology,pathogenesis,diagnosis,and treatment[J].Am J Hematol,2003,72(1):43-52.
  • 2Luxembourg B,Bauersachs R.Malignancy and thrombosis;a double-sided clinical relationship[J].Vasa,2005,34(4):225-234.
  • 3曹健鹏,李俊海.恶性肿瘤并发DVT的临床观察[J].中国肿瘤临床,2010,37(24):1486-1488. 被引量:8
  • 4Uaprasert N,Voorhees PM,Mackman N,et al.Venous thromboembolism in multiple myeloma.Current perspectives in pathogenesis[J].Eur J Cancer,2010,46(16):1790-1799.
  • 5Prandoin P,Falanga A,Piccioli A.Cancer and venous thromboembolism[J].Lancet Oncol,2005,6(6):401.
  • 6何文.下肢深静脉血栓形成的超声检查[J].中华医学杂志,2003,83(7):615-616. 被引量:133
  • 7内科住院患者静脉血栓栓塞症预防的中国专家建议[J].中华老年医学杂志,2009,28(1):1-7. 被引量:34
  • 8Lyman GH,Khorana AA,Falanga A,et al.American Society of Clinical Oncology guideline:recommendations for venous thromboebolism prophylaxis and treatment in patients with cancer[J].J Clin Oncol,2007,25(34):5490.
  • 9Kakkar AK,Levine MN,Kadziola Z,et al.Low molecular weight heparin,therapy with dalteparin,and survival in advanced cancer:The fragmin advanced malignancy outcome study(FAMOUS)[J].J Clin Oncol,2004,22(15):1944.
  • 10El Accaoui RN,Shamseddeen WA,Taher AT.Thalidomide,andthrombosis.A meta-analysis[J].Thromb Haemost,2007,97(6):1031-1036.

二级参考文献49

  • 1Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med, 1989, 82 : 203-205.
  • 2Cardiovascular Disease Educational and Research Trust, Cyprus Cardiovascular Disease Educational and Research Trust, European Venous Forum, et al.Prevention and treatment of venous thromboembolism. International Consensus statement (guidelines according to scientific evidence). Int Angiol, 2006, 25: 101-161.
  • 3Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromhoembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med, 1999, 341: 793-800.
  • 4Leizorovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation, 2004, 110 Suppl 1: Ⅳ13-Ⅳ19.
  • 5Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ, 2006, 332: 325-329
  • 6Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med, 2000, 161: 1109-1114.
  • 7Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA, 1995, 274: 335-337.
  • 8Spyropoulos AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest, 2005, 128: 958-969.
  • 9Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost, 2005, 94: 750-759.
  • 10Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ, 1991, 302: 709-711.

共引文献171

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部